Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast

Journal of Pathology

Volumn 194, Issue 1, 2001, Pages 35-42

  Wong, Sze Chuen C ^a   Chan, John K C ^b   Lee, King Chung ^b   Wendy Hsiao, W L ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Apoptosis; Breast; C myc; CDK inhibitors; Cyclin D1; Cyclin D3; Ductal carcinoma; Ki 67; P16; P21; P27

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN D3; KI 67 ANTIGEN; MYC PROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P27;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER GRADING; CANCER INVASION; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DISEASE PROGRESSION; FEMALE; HUMANS; IN SITU NICK-END LABELING; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0035042153     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.838     Document Type: Article

References (28)

1. Perspective: Defects in cell cycle control and cancer
2. Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas
3. New functional activities for the p21 family of CDK inhibitors
4. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
5. CDK inhibitors: Positive and negative regulators of G1-phase progression
6. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
7. Negative control elements of the cell cycle in human tumors
8. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis
9. Re-expression of P16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression
10. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia
11. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer
12. Cancer cell cycles
13. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity
14. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)
15. Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases
16. Expression of c-myc proteins in breast cancer as related to established dprognostic factors and survival
17. The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors
18. Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma
19. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers
20. Proteins of the Myc network: Essential regulators of cell growth and differentiation
21. Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer
22. INK4a in prirnary and metastatic breast carcinoma as compared to normal breast tissue
23. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
24. Chromosome 11q13 markers and D-type cyclins in breast cancer
25. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia
26. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4
27. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
28. Aberrations of the G1- and G1/S-regulating genes in human cancer